A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
Recruiting · NCT07170800 · Registry updated 2026-01-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, rifampicin-resistant tuberculosis, tuberculosis | Recruiting | Phase 2 | 2026-01-30 | NCT07170800 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| WestVac Biopharma Co., Ltd. | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Chest Hospital, Capital Medical University | Beijing | China | 7 |
| Changsha Central Hospital | Changsha | China | 4 |
| Huashan Hospital Fudan University | Shanghai | China | 3 |
| Public Health Clinical Center of Chengdu | Chengdu | China | 2 |
| Shandong Public Health Clinical Center | Jinan | China | 2 |
| The Second Hospital of Nanjing | Nanjing | China | 5 |
| Wuhan Pulmonary Hospital | Wuhan | China | 1 |